AN OPEN LABEL STUDY OF THE SAFETY, EFFICACY AND PHARMACOKINETICS OF GLYCEROL PHENYLBUTYRATE (GPB; RAVICTI®) IN PEDIATRIC SUBJECTS UNDER TWO YEARS OF AGE WITH UREA CYCLE DISORDERS (UCDS)

Registry ID

HPN-100-009

Source registry

HEALTH_CANADA

Status

Closed

Study type

INTERVENTIONAL

Sponsor

HORIZON PHARMA IRELAND LTD

Start date

2016-12-15

Completion date

2017-07-17

Last update

2014-10-02

Conditions

• UREA CYCLE DISORDERS

View on source registry